Bruce Culleton - Sep 13, 2024 Form 4 Insider Report for PROKIDNEY CORP. (PROK)

Role: Chief Executive Officer, Director
Signature: /s/ Todd Girolamo, attorney in fact
Stock symbol: PROK
Transactions as of: Sep 13, 2024
Transactions value $: $0
Form type: 4
Date filed: 9/16/2024, 05:31 PM
Previous filing: Dec 5, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PROK	Employee stock option (right to buy)	Award	$0	+500K		$0.00	500K	Sep 13, 2024	Class A Ordinary Shares	500K	$1.69	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This performance-based stock option was granted on December 3, 2023. On September 13, 2024, the Company's board of directors certified achievement of the performance goal at 100%. In addition to the achievement of the performance goal, the options are subject to time vesting requirements under which 25% vested on September 13, 2024 and the remaining 75% vests in equal installments of 125,000 shares on each of November 15, 2024, February 15, 2025 and May 15, 2025.

Content

This performance-based stock option was granted on December 3, 2023. On September 13, 2024, the Company's board of directors certified achievement of the performance goal at 100%. In addition to the achievement of the performance goal, the options are subject to time vesting requirements under which 25% vested on September 13, 2024 and the remaining 75% vests in equal installments of 125,000 shares on each of November 15, 2024, February 15, 2025 and May 15, 2025.